Observational studyFrontiers in immunology2026
Data-driven serum cytokine and chemokine phenotypes are associated with MRI-defined disc regression and persistent radicular pain in lumbar disc herniation.
Observational study in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Inflammation after lumbar disc herniation (LDH) may contribute to radicular pain while also participating in resorption of herniated disc material. Whether circulating immune profiles are associated with these endpoint-specific recovery patterns remains uncertain. Methods: This single-center observational cohort included patients with symptomatic LDH treated between 1 January 2023 and 30 November 2025. Stored baseline serum IL-6, IL-8/CXCL8, CCL2/MCP-1, and MMP-9 were log-transformed, standardized, and entered into outcome-blinded Gaussian mixture modeling. MRI-defined regression (>=50% volume reduction during nonoperative follow-up) and persistent radicular pain (recorded follow-up leg-pain VAS >=3) were analyzed in endpoint-specific cohorts. Selection weighting, early-surgery-as-failure, classification-certainty, storage-adjusted, continuous-outcome, and penalized-model sensitivity analyses were performed. Results: Among 146 patients with complete four-marker data, the BIC-preferred EII three-class solution identified low immune activation (n=46), cytokine-dominant (n=32), and chemokine/MMP-dominant (n=68) phenotypes (Delta BIC 7.29 versus the next-best model). In the paired-MRI cohort (N = 117), regression occurred in 52.6%, 40.9%, and 71.9%, respectively. The chemokine/MMP-dominant phenotype was associated with MRI regression in the primary adjusted model (OR 2.99, 95% CI 1.11-8.08; P = 0.031; global P = 0.019), and adjusted continuous volume reduction was 9.88 percentage points greater than in the low-activation group (95% CI 0.08-19.68; P = 0.048). Several sensitivity analyses retained the direction but widened uncertainty, including nonlinear-age, early-surgery, and posterior-certainty analyses. In the persistent-pain cohort (N = 123), the categorical phenotype association was heterogeneous but class-specific estimates were imprecise; the continuous IL-6/IL-8 cytokine axis showed the clearest association with persistent pain (OR per 1-SD 2.38, 95% CI 1.34-4.21; P = 0.003). Conclusion: Baseline serum immune profiles were associated with endpoint-specific structural and pain outcomes in LDH. The chemokine/MMP-dominant phenotype showed the clearest association with MRI-defined regression, whereas persistent pain was more consistently related to a continuous cytokine axis. These observational findings are hypothesis-generating and require prospective multicenter and tissue-level validation before clinical use.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.